Tiburio Therapeutics
About:
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Website: https://www.tiburio.com/
Twitter/X: tiburiot/
Top Investors: New Enterprise Associates, Alexandria Venture Investments, Longitude Capital, Lundbeckfonden Ventures
Description:
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.The company's compounds aid in the treatment of non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, providing patients with effective treatment for rare neuroendocrine tumors and endocrine diseases.
$31M
$1M to $10M
Cambridge, Massachusetts, United States
2018-01-01
nfo(AT)tiburio.com
Chris Adams, Imran Babar, James McArthur, Michael Culler
1-10
2019-01-03
Private
© 2025 bioDAO.ai